Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
| Autor: | Carlino, G., Fornaro, M., Santo, L., Bucci, R., Semeraro, A., Quarta, L., D'Onofrio, F., Marsico, A., Zuccaro, C., Falappone, P. C., Mazzott, D., Cantatore, F. P., Muratore, M., Iannone, F. |
|---|---|
| Zdroj: | Reumatismo; 2019, Vol. 71 Issue 1, p24-30, 7p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|